CCA
GILD icon

Clearwater Capital Advisors’s Gilead Sciences GILD Stock Holding History

Clearwater Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-132
Closed -$10K – 326
2018
Q1 		$10K Buy
+132
New +$10.5K ﹤0.01% 477

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clearwater Capital Advisors's GILD Position: Q2 2018 in Review

Clearwater Capital Advisors sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 132 shares — an estimated $10K sold.

Clearwater Capital Advisors first reported a position in GILD in Q1 2018 and held it in 1 quarter. The position peaked at $10K in Q1 2018. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Clearwater Capital Advisors reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Clearwater Capital Advisors sold 132 Gilead Sciences shares in Q2 2018, an estimated $10K.
  • Clearwater Capital Advisors first reported a position in Gilead Sciences in Q1 2018 and held it in 1 quarter.
  • Clearwater Capital Advisors's Gilead Sciences position peaked at $10K in Q1 2018.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Clearwater Capital Advisors's 13F filing for Q2 2018, filed 16 Aug 2018.